Clinical Study on Surgical Treatment of Hypertrophic Obstructive Cardiomyopathy Guided by 3D Printing Technology

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000034571

Enrollment

Unknown

Registered

2020-07-10

Start date

2020-06-30

Completion date

Unknown

Last updated

2020-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertrophic obstructive cardiomyopathy

Interventions

3D printing group :3D printing guidance before operation

Two dimensional ultrasound guidance group :Preoperative ultrasound guidance

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients with clinical symptoms of chest pain, chest tightness and syncope are not well treated or can not tolerate drugs; 2. Patients with left ventricular outflow tract pressure gradient >=50mmhg, without mitral valve organic disease: such as valve ring enlargement, tendon cord extension or rupture, endocarditis, etc.

Exclusion criteria

Exclusion criteria: 1. The patients whose symptoms can be controlled and cardiac function can be improved by drug treatment are not up to the standard of operation; 2. The patients with poor general condition, unable to tolerate thoracotomy, and patients who subjectively refuse thoracotomy.

Design outcomes

Primary

Measure	Time frame
Operation time;Peak gradients of left ventricular outflow tract;	—

Countries

China

Contacts

Public ContactShuiyun Wang

Fuwai Hospital, Chinese Academy of Medical Sciences

wsymd@sina.com+86 13701176101

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026